Norges Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59B | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.37B | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.61B | Sell |
|
|||||
|
2024
Q1 | $1.45B | Buy |
|
|||||
|
2023
Q4 | $1.24B | Buy |
|
|||||
|
2023
Q3 | $930M | Buy |
|
|||||
|
2023
Q2 | $918M | Buy |
|
|||||
|
2023
Q1 | $797M | Buy |
|
|||||
|
2022
Q4 | $708M | Buy |
|
|||||
|
2022
Q3 | $663M | Buy |
|
|||||
|
2022
Q2 | $627M | Sell |
|
|||||
|
2022
Q1 | $685M | Sell |
|
|||||
|
2021
Q4 | $589M | Buy |
|
|||||
|
2021
Q3 | $458M | Sell |
|
|||||
|
2021
Q2 | $514M | Sell |
|
|||||
|
2021
Q1 | $567M | Sell |
|
|||||
|
2020
Q4 | $655M | Sell |
|
|||||
|
2020
Q3 | $779M | Buy |
|
|||||
|
2020
Q2 | $780M | Buy |
|
|||||
|
2020
Q1 | $604M | Buy |
|
|||||
|
2019
Q4 | $551M | Buy |
|
|||||
|
2019
Q3 | $404M | Hold |
|
|||||
|
2019
Q2 | $437M | Hold |
|
|||||
|
2019
Q1 | $438M | Buy |
|
|||||
|
2018
Q4 | $381M | Sell |
|
|||||
|
2018
Q3 | $448M | Sell |
|
|||||
|
2018
Q2 | $402M | Sell |
|
|||||
|
2018
Q1 | $397M | Buy |
|
|||||
|
2017
Q4 | $351M | Buy |
|
|||||
|
2017
Q3 | $327M | Buy |
|
|||||
|
2017
Q2 | $261M | Sell |
|
|||||
|
2017
Q1 | $235M | Buy |
|
|||||
|
2016
Q4 | $128M | Buy |
|
|||||
|
2016
Q3 | $140M | Hold |
|
|||||
|
2016
Q2 | $144M | Sell |
|
|||||
|
2016
Q1 | $137M | Sell |
|
|||||
|
2015
Q4 | $223M | Buy |
|
|||||
|
2015
Q3 | $184M | Buy |
|
|||||
|
2015
Q2 | $203M | Buy |
|
|||||
|
2015
Q1 | $188M | Sell |
|
|||||
|
2014
Q4 | $191M | Buy |
|
|||||
|
2014
Q3 | $173M | Sell |
|
|||||
|
2014
Q2 | $292M | Buy |
|
|||||
|
2014
Q1 | $108M | Hold |
|
|||||
|
2013
Q4 | $114M | Sell |
|
|||||
|
2013
Q3 | $144M | Buy |
|
|||||
|
2013
Q2 | $69.3M | Buy |
|